Ceftriaxone + LidocaineThird Party Manufacturing in India

Ceftriaxone + Lidocaine works by combining a broad-spectrum, third-generation cephalosporin antibiotic with a local anesthetic to deliver effective treatment with minimized patient discomfort during administration.

Ceftriaxone acts by binding to penicillin-binding proteins (PBPs) in the bacterial cell wall, which inhibits the transpeptidation process during cell division. This prevents peptidoglycan cross-linking, weakening the cell wall and causing osmotic lysis and bacterial death. Lidocaine is a local anesthetic that works by blocking voltage-gated sodium channels in neuronal membranes. This blockade inhibits the initiation and conduction of nerve impulses, temporarily numbing the local area and blocking pain signals.

Unlike standard intravenous cephalosporin formulations, this combination is formulated as a combipack specifically for intramuscular injection. The inclusion of Lidocaine as the diluent significantly reduces the intense pain associated with deep intramuscular administration. This combination must never be administered intravenously.

Therapeutic Uses

Ceftriaxone + Lidocaine is prescribed for the treatment of:

• Gonorrhea: Used as a single-dose intramuscular treatment for uncomplicated gonococcal infections.
• Acute Otitis Media: Administered to pediatric patients when oral antibiotic therapy is not feasible.
• Uncomplicated Urinary Tract Infections: Prescribed for patients requiring outpatient injectable therapy.
• Community-Acquired Pneumonia: Used in outpatient settings for initial management of respiratory infections.
• Skin and Soft Tissue Infections: Treat moderate localized bacterial infections in an outpatient environment.

Why Partner with a WHO-GMP Ceftriaxone + Lidocaine Manufacturer

Ceftriaxone + Lidocaine third party manufacturing in India is highly popular for outpatient care products. Because Ceftriaxone intramuscular injections can be extremely painful, the combipack offering Lidocaine as the solvent is preferred by general practitioners, clinics, and pediatricians to improve patient compliance.

Working with a WHO-GMP contract manufacturer guarantees that the combipack contains sterile Ceftriaxone powder alongside a separate, sterile Lidocaine ampoule. This dual-component packaging requires specialized co-packaging lines and stringent quality assays to ensure the safety, sterility, and correct dosing of both active pharmaceutical ingredients, making it an excellent product for PCD franchise marketing.